Cost analysis of plasma-derived factor VIII/von Willebrand factor versus recombinant factor VIII for treatment of previously untreated patients with severe hemophilia A in the United States-Reference-Cited by-同舟云学术

Cost analysis of plasma-derived factor VIII/von Willebrand factor versus recombinant factor VIII for treatment of previously untreated patients with severe hemophilia A in the United States

Published:2018-06-06 Issue:8 Volume:21 Page:762-769
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Neufeld Ellis J.¹,Sidonio Robert F.²,O’Day Ken³,Runken M. Chris⁴,Meyer Kellie³,Spears Jeffrey⁴

Affiliation:

1. St Jude Children’s Research Hospital, Memphis, TN, USA;

2. Emory University and Aflac Cancer and Blood Disorders, Atlanta, GA, USA;

3. Xcenda, Palm Harbor, FL, USA;

4. Grifols, Research Triangle Park, NC, USA

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2018.1468335

Reference47 articles.

1. Methods to treat chronic haemophilic synovitis

2. A study of prospective surveillance for inhibitors among persons with haemophilia in the United States

3. Incidence of factor VIII inhibitors throughout life in severe hemophilia A in the United Kingdom

4. Prevention of bleeds in hemophilia patients with inhibitors: Emerging data and clinical direction

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shifting Paradigms and Arising Concerns in Severe Hemophilia A Treatment;Seminars in Thrombosis and Hemostasis;2024-01-15

2. Are We Capturing the Socioeconomic Burden of Rare Genetic Disease? A Scoping Review of Economic Evaluations and Cost-of-Illness Studies;PharmacoEconomics;2023-08-18

3. Correlation Analysis of DNA Methylation in the von Willebrand Factor Promoter Region and the Risk of Unexplained Recurrent Hemophilia: Systematic Review and Meta-Analysis;Contrast Media & Molecular Imaging;2022-06-03

4. Health and treatment outcomes of patients with hemophilia in the Netherlands, 1972–2019;Journal of Thrombosis and Haemostasis;2021-07-07

5. Structure of Blood Coagulation Factor VIII in Complex With an Anti-C2 Domain Non-Classical, Pathogenic Antibody Inhibitor;Frontiers in Immunology;2021-06-10